Margaret McLoughlin

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Brendan Hannah as attorney-in-fact for Margaret McLoughlin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Margaret McLoughlin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Director Director Stock Option (Right to Buy) 19,547 02 Jan 2026 Direct

Insider Reports Filed by Margaret McLoughlin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QNCX Quince Therapeutics, Inc. 02 Jan 2026 1 $0 4 Director 21 Jan 2026, 18:10
QNCX Quince Therapeutics, Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:27
QNCX Quince Therapeutics, Inc. 02 Jan 2025 1 $0 4 Director 08 Jan 2025, 19:33
QNCX Quince Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 21:04
QNCX Quince Therapeutics, Inc. 08 Aug 2023 1 +$9,840 4 Director 09 Aug 2023, 18:18
QNCX Quince Therapeutics, Inc. 24 May 2023 1 $0 4 Director 26 May 2023, 17:49
QNCX Cortexyme, Inc. 08 Jun 2022 1 $0 4 Director 09 Jun 2022, 20:41
QNCX Cortexyme, Inc. 08 Oct 2021 3 -$71,930 4 Director 12 Oct 2021, 17:48
QNCX Cortexyme, Inc. 16 Aug 2021 7 -$470,644 4 Director 18 Aug 2021, 17:30
QNCX Cortexyme, Inc. 28 Jun 2021 3 -$30,332 4 Director 29 Jun 2021, 17:26
QNCX Cortexyme, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 19:27